Treace Medical Concepts, Inc. Deferred Tax Liabilities, Other Finite-Lived Assets
Treace Medical Concepts, Inc. (TMCI) had Deferred Tax Liabilities, Other Finite-Lived Assets of $1.89 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets · last filed 2026-02-27
- 2025-12-31: Deferred Tax Liabilities, Other Finite-Lived Assets $1.89M.
- 2024-12-31: Deferred Tax Liabilities, Other Finite-Lived Assets $2.01M.
- 2023-12-31: Deferred Tax Liabilities, Other Finite-Lived Assets $2.22M.
- 2022-12-31: Deferred Tax Liabilities, Other Finite-Lived Assets $2.33M.
| Period end | Deferred Tax Liabilities, Other Finite-Lived Assets |
|---|---|
| 2025-12-31 | $1.89M 10-K · filed 2026-02-27 |
| 2024-12-31 | $2.01M 10-K · filed 2026-02-27 |
| 2023-12-31 | $2.22M 10-K · filed 2025-02-27 |
| 2022-12-31 | $2.33M 10-K · filed 2024-02-27 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |